Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 65 entries
Sorted by: Best Match Show Resources per page
Mannitol bronchial challenge test in asthmatic children.

Journal of biological regulators and homeostatic agents

Miraglia Del Giudice M, Capristo C, Decimo F, Coronella A, Indolfi C, Parisi G, Maiello N.
PMID: 26634590
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):70-2.

Bronchial asthma is a chronic inflammatory disease characterized by bronchial obstruction, usually reversible spontaneously or after therapy, bronchial hyperreactivity and accelerated decrease of lung function that may possibly evolve into irreversible obstruction of the respiratory tract. Bronchial provocation tests...

Cite
Miraglia Del Giudice M, Capristo C, Decimo F, et al. Mannitol bronchial challenge test in asthmatic children. J Biol Regul Homeost Agents. 2015;29(2):70-2
Miraglia Del Giudice, M., Capristo, C., Decimo, F., Coronella, A., Indolfi, C., Parisi, G., & Maiello, N. (2015). Mannitol bronchial challenge test in asthmatic children. Journal of biological regulators and homeostatic agents, 29(2), 70-2.
Miraglia Del Giudice, M, et al. "Mannitol bronchial challenge test in asthmatic children." Journal of biological regulators and homeostatic agents vol. 29,2 (2015): 70-2.
Miraglia Del Giudice M, Capristo C, Decimo F, Coronella A, Indolfi C, Parisi G, Maiello N. Mannitol bronchial challenge test in asthmatic children. J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):70-2. PMID: 26634590.
Copy Download .nbib Format: NLM
SUBLINGUAL IMMUNOTHERAPY IN CHILDREN: STATE OF ART.

Journal of biological regulators and homeostatic agents

Alterio T, Manti S, Colavita L, Marseglia L, Sturiale M, Miraglia Del Giudice M, Salpietro A, Cuppari C.
PMID: 26634597
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):120-4.

Allergic immunotherapy (AIT) today represents a therapeutic practice for the treatment of allergic diseases such as rhinitis or asthma and is recognized as the only treatment able to modify the natural history of the disease. Administering gradually increasing doses...

Cite
Alterio T, Manti S, Colavita L, et al. SUBLINGUAL IMMUNOTHERAPY IN CHILDREN: STATE OF ART. J Biol Regul Homeost Agents. 2015;29(2):120-4
Alterio, T., Manti, S., Colavita, L., Marseglia, L., Sturiale, M., Miraglia Del Giudice, M., Salpietro, A., & Cuppari, C. (2015). SUBLINGUAL IMMUNOTHERAPY IN CHILDREN: STATE OF ART. Journal of biological regulators and homeostatic agents, 29(2), 120-4.
Alterio, T, et al. "SUBLINGUAL IMMUNOTHERAPY IN CHILDREN: STATE OF ART." Journal of biological regulators and homeostatic agents vol. 29,2 (2015): 120-4.
Alterio T, Manti S, Colavita L, Marseglia L, Sturiale M, Miraglia Del Giudice M, Salpietro A, Cuppari C. SUBLINGUAL IMMUNOTHERAPY IN CHILDREN: STATE OF ART. J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):120-4. PMID: 26634597.
Copy Download .nbib Format: NLM
β2-AGONISTS IN CHILDHOOD ASTHMA.

Journal of biological regulators and homeostatic agents

Miraglia Del Giudice M, Campana G, Galdo F, De Vivo D, Cuppari C, Coronella A, Maiello N.
PMID: 26634602
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):137-41.

β2-agonists reduce airflow limitation by improving airway diameter as a consequence of a direct action on airway smooth muscle. β;2-agonists can be broadly classified according to their duration of action: short-acting β2-agonists (SABAs), including albuterol, terbutaline and fenoterol, have...

Cite
Miraglia Del Giudice M, Campana G, Galdo F, et al. β2-AGONISTS IN CHILDHOOD ASTHMA. J Biol Regul Homeost Agents. 2015;29(2):137-41
Miraglia Del Giudice, M., Campana, G., Galdo, F., De Vivo, D., Cuppari, C., Coronella, A., & Maiello, N. (2015). β2-AGONISTS IN CHILDHOOD ASTHMA. Journal of biological regulators and homeostatic agents, 29(2), 137-41.
Miraglia Del Giudice, M, et al. "β2-AGONISTS IN CHILDHOOD ASTHMA." Journal of biological regulators and homeostatic agents vol. 29,2 (2015): 137-41.
Miraglia Del Giudice M, Campana G, Galdo F, De Vivo D, Cuppari C, Coronella A, Maiello N. β2-AGONISTS IN CHILDHOOD ASTHMA. J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):137-41. PMID: 26634602.
Copy Download .nbib Format: NLM
Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values.

World journal of clinical cases

Marzuillo P, Guarino S, Esposito T, Di Sessa A, Orsini SI, Capalbo D, Miraglia Del Giudice E, La Manna A.
PMID: 31123674
World J Clin Cases. 2019 May 06;7(9):1021-1027. doi: 10.12998/wjcc.v7.i9.1021.

BACKGROUND: In paediatric patients with complicated nephrotic syndrome (NS), rituximab (RTX) administration can induce persistent IgG hypogammaglobulinemia among subjects showing low basal immunoglobulin G (IgG) levels.AIM: To evaluate the effect of RTX on IgG levels and infections in patients...

Cite
Marzuillo P, Guarino S, Esposito T, et al. Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values. World J Clin Cases. 2019;7(9):1021-1027doi: 10.12998/wjcc.v7.i9.1021.
Marzuillo, P., Guarino, S., Esposito, T., Di Sessa, A., Orsini, S. I., Capalbo, D., Miraglia Del Giudice, E., & La Manna, A. (2019). Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values. World journal of clinical cases, 7(9), 1021-1027. https://doi.org/10.12998/wjcc.v7.i9.1021
Marzuillo, Pierluigi, et al. "Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values." World journal of clinical cases vol. 7,9 (2019): 1021-1027. doi: https://doi.org/10.12998/wjcc.v7.i9.1021
Marzuillo P, Guarino S, Esposito T, Di Sessa A, Orsini SI, Capalbo D, Miraglia Del Giudice E, La Manna A. Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values. World J Clin Cases. 2019 May 06;7(9):1021-1027. doi: 10.12998/wjcc.v7.i9.1021. PMID: 31123674; PMCID: PMC6511933.
Copy Download .nbib Format: NLM
Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients.

Cancers

Scappaticcio L, Maiorino MI, Iorio S, Docimo G, Longo M, Grandone A, Luongo C, Cozzolino I, Piccardo A, Trimboli P, Miraglia Del Giudice E, Esposito K, Bellastella G.
PMID: 34771467
Cancers (Basel). 2021 Oct 22;13(21). doi: 10.3390/cancers13215304.

Neck ultrasound (nUS) is the cornerstone of clinical management of thyroid nodules in pediatric patients, as well as adults. The current study was carried out to explore and compare the diagnostic performance of the main US-based risk stratification systems...

Cite
Scappaticcio L, Maiorino MI, Iorio S, et al. Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients. Cancers (Basel). 2021;13(21)doi: 10.3390/cancers13215304.
Scappaticcio, L., Maiorino, M. I., Iorio, S., Docimo, G., Longo, M., Grandone, A., Luongo, C., Cozzolino, I., Piccardo, A., Trimboli, P., Miraglia Del Giudice, E., Esposito, K., & Bellastella, G. (2021). Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients. Cancers, 13(21), . https://doi.org/10.3390/cancers13215304
Scappaticcio, Lorenzo, et al. "Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients." Cancers vol. 13,21 (2021). doi: https://doi.org/10.3390/cancers13215304
Scappaticcio L, Maiorino MI, Iorio S, Docimo G, Longo M, Grandone A, Luongo C, Cozzolino I, Piccardo A, Trimboli P, Miraglia Del Giudice E, Esposito K, Bellastella G. Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients. Cancers (Basel). 2021 Oct 22;13(21). doi: 10.3390/cancers13215304. PMID: 34771467; PMCID: PMC8582568.
Copy Download .nbib Format: NLM
Biologic drugs in chronic spontaneous urticaria.

Acta bio-medica : Atenei Parmensis

Licari A, Manti S, Leonardi S, Minasi D, Caffarelli C, Cardinale F, Miraglia Del Giudice M, Calvani M, Ciprandi G, Marseglia GL.
PMID: 34842589
Acta Biomed. 2021 Nov 29;92:e2021527. doi: 10.23750/abm.v92iS7.12415.

Chronic spontaneous urticaria (CSU) is a condition defined by the presence of recurrent urticaria, angioedema, or both, which persist for more than six weeks in duration and occurs in the absence of an identifiable trigger. Both children and adults...

Cite
Licari A, Manti S, Leonardi S, et al. Biologic drugs in chronic spontaneous urticaria. Acta Biomed. 2021;92:e2021527doi: 10.23750/abm.v92iS7.12415.
Licari, A., Manti, S., Leonardi, S., Minasi, D., Caffarelli, C., Cardinale, F., Miraglia Del Giudice, M., Calvani, M., Ciprandi, G., & Marseglia, G. L. (2021). Biologic drugs in chronic spontaneous urticaria. Acta bio-medica : Atenei Parmensis, 92e2021527. https://doi.org/10.23750/abm.v92iS7.12415
Licari, Amelia, et al. "Biologic drugs in chronic spontaneous urticaria." Acta bio-medica : Atenei Parmensis vol. 92 (2021): e2021527. doi: https://doi.org/10.23750/abm.v92iS7.12415
Licari A, Manti S, Leonardi S, Minasi D, Caffarelli C, Cardinale F, Miraglia Del Giudice M, Calvani M, Ciprandi G, Marseglia GL. Biologic drugs in chronic spontaneous urticaria. Acta Biomed. 2021 Nov 29;92:e2021527. doi: 10.23750/abm.v92iS7.12415. PMID: 34842589.
Copy Download .nbib Format: NLM
Digital health in the management of allergic diseases.

Acta bio-medica : Atenei Parmensis

Pattini S, Pingitore G, Cardinale F, Licari A, Miraglia Del Giudice M, Calvani M, Chiappini E, Cravidi C, Marseglia GL, Ricci G, Duse M, Tripodi S.
PMID: 34842591
Acta Biomed. 2021 Nov 29;92:e2021529. doi: 10.23750/abm.v92iS7.12405.

In recent years there has been an important implementation in the medical field of both Mobile Health, such as the use of mobile communication devices, and of other telemedicine tools in general, with the aim of supporting the supervision...

Cite
Pattini S, Pingitore G, Cardinale F, et al. Digital health in the management of allergic diseases. Acta Biomed. 2021;92:e2021529doi: 10.23750/abm.v92iS7.12405.
Pattini, S., Pingitore, G., Cardinale, F., Licari, A., Miraglia Del Giudice, M., Calvani, M., Chiappini, E., Cravidi, C., Marseglia, G. L., Ricci, G., Duse, M., & Tripodi, S. (2021). Digital health in the management of allergic diseases. Acta bio-medica : Atenei Parmensis, 92e2021529. https://doi.org/10.23750/abm.v92iS7.12405
Pattini, Stefano, et al. "Digital health in the management of allergic diseases." Acta bio-medica : Atenei Parmensis vol. 92 (2021): e2021529. doi: https://doi.org/10.23750/abm.v92iS7.12405
Pattini S, Pingitore G, Cardinale F, Licari A, Miraglia Del Giudice M, Calvani M, Chiappini E, Cravidi C, Marseglia GL, Ricci G, Duse M, Tripodi S. Digital health in the management of allergic diseases. Acta Biomed. 2021 Nov 29;92:e2021529. doi: 10.23750/abm.v92iS7.12405. PMID: 34842591.
Copy Download .nbib Format: NLM
Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report.

Journal of diabetes science and technology

Zanfardino A, Carpentieri M, Piscopo A, Curto S, Miraglia Del Giudice E, Inverardi A, Diplomatico M, Moschella S, Spagnuolo F, Caredda E, Montaldo P, Iafusco D.
PMID: 34474595
J Diabetes Sci Technol. 2022 Jan;16(1):254-255. doi: 10.1177/19322968211043112. Epub 2021 Sep 02.

No abstract available.

Cite
Zanfardino A, Carpentieri M, Piscopo A, et al. Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report. J Diabetes Sci Technol. 2021;16(1):254-255doi: 10.1177/19322968211043112.
Zanfardino, A., Carpentieri, M., Piscopo, A., Curto, S., Miraglia Del Giudice, E., Inverardi, A., Diplomatico, M., Moschella, S., Spagnuolo, F., Caredda, E., Montaldo, P., & Iafusco, D. (2022). Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report. Journal of diabetes science and technology, 16(1), 254-255. https://doi.org/10.1177/19322968211043112
Zanfardino, Angela, et al. "Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report." Journal of diabetes science and technology vol. 16,1 (2022): 254-255. doi: https://doi.org/10.1177/19322968211043112
Zanfardino A, Carpentieri M, Piscopo A, Curto S, Miraglia Del Giudice E, Inverardi A, Diplomatico M, Moschella S, Spagnuolo F, Caredda E, Montaldo P, Iafusco D. Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report. J Diabetes Sci Technol. 2022 Jan;16(1):254-255. doi: 10.1177/19322968211043112. Epub 2021 Sep 02. PMID: 34474595.
Copy Download .nbib Format: NLM
Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study.

Children (Basel, Switzerland)

Marzuillo P, Di Sessa A, Palma PL, Umano GR, Polito C, Iafusco D, Guarino S, Miraglia Del Giudice E.
PMID: 34438518
Children (Basel). 2021 Jul 23;8(8). doi: 10.3390/children8080627.

Type 2 Diabetes Mellitus (T2DM) is a main cause of chronic kidney disease (CKD) in adulthood. No studies have examined the occurrence of acute kidney injury (AKI)-that enhances the risk of later CKD-and renal tubular damage (RTD)-that can evolve...

Cite
Marzuillo P, Di Sessa A, Palma PL, et al. Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study. Children (Basel). 2021;8(8)doi: 10.3390/children8080627.
Marzuillo, P., Di Sessa, A., Palma, P. L., Umano, G. R., Polito, C., Iafusco, D., Guarino, S., & Miraglia Del Giudice, E. (2021). Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study. Children (Basel, Switzerland), 8(8), . https://doi.org/10.3390/children8080627
Marzuillo, Pierluigi, et al. "Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study." Children (Basel, Switzerland) vol. 8,8 (2021). doi: https://doi.org/10.3390/children8080627
Marzuillo P, Di Sessa A, Palma PL, Umano GR, Polito C, Iafusco D, Guarino S, Miraglia Del Giudice E. Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study. Children (Basel). 2021 Jul 23;8(8). doi: 10.3390/children8080627. PMID: 34438518; PMCID: PMC8392677.
Copy Download .nbib Format: NLM
Focus on the cetirizine use in clinical practice: a reappraisal 30 years later.

Multidisciplinary respiratory medicine

Corsico AG, Leonardi S, Licari A, Marseglia G, Miraglia Del Giudice M, Peroni DG, Salpietro C, Ciprandi G.
PMID: 31827796
Multidiscip Respir Med. 2019 Dec 06;14:40. doi: 10.1186/s40248-019-0203-6. eCollection 2019.

Antihistamines are currently one of the most commonly administered categories of drugs. They are used to treat symptoms that are secondary to histamine release, which is typical of certain allergic conditions, including rhinitis, conjunctivitis, asthma, urticaria, and anaphylaxis. Cetirizine...

Cite
Corsico AG, Leonardi S, Licari A, et al. Focus on the cetirizine use in clinical practice: a reappraisal 30 years later. Multidiscip Respir Med. 2019;14:40doi: 10.1186/s40248-019-0203-6.
Corsico, A. G., Leonardi, S., Licari, A., Marseglia, G., Miraglia Del Giudice, M., Peroni, D. G., Salpietro, C., & Ciprandi, G. (2019). Focus on the cetirizine use in clinical practice: a reappraisal 30 years later. Multidisciplinary respiratory medicine, 1440. https://doi.org/10.1186/s40248-019-0203-6
Corsico, Angelo G, et al. "Focus on the cetirizine use in clinical practice: a reappraisal 30 years later." Multidisciplinary respiratory medicine vol. 14 (2019): 40. doi: https://doi.org/10.1186/s40248-019-0203-6
Corsico AG, Leonardi S, Licari A, Marseglia G, Miraglia Del Giudice M, Peroni DG, Salpietro C, Ciprandi G. Focus on the cetirizine use in clinical practice: a reappraisal 30 years later. Multidiscip Respir Med. 2019 Dec 06;14:40. doi: 10.1186/s40248-019-0203-6. eCollection 2019. PMID: 31827796; PMCID: PMC6898951.
Copy Download .nbib Format: NLM
Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians.

Children (Basel, Switzerland)

Parisi GF, Diaferio L, Brindisi G, Indolfi C, Umano GR, Klain A, Marchese G, Ghiglioni DG, Zicari AM, Marseglia GL, Miraglia Del Giudice M.
PMID: 34572201
Children (Basel). 2021 Aug 31;8(9). doi: 10.3390/children8090769.

The persistence of symptoms after recovery from Coronavirus 2019 (COVID-19) is defined as long COVID, an entity that had occurred among adults but which is not yet well characterized in pediatric ages. The purpose of this work was to...

Cite
Parisi GF, Diaferio L, Brindisi G, et al. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children (Basel). 2021;8(9)doi: 10.3390/children8090769.
Parisi, G. F., Diaferio, L., Brindisi, G., Indolfi, C., Umano, G. R., Klain, A., Marchese, G., Ghiglioni, D. G., Zicari, A. M., Marseglia, G. L., & Miraglia Del Giudice, M. (2021). Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children (Basel, Switzerland), 8(9), . https://doi.org/10.3390/children8090769
Parisi, Giuseppe Fabio, et al. "Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians." Children (Basel, Switzerland) vol. 8,9 (2021). doi: https://doi.org/10.3390/children8090769
Parisi GF, Diaferio L, Brindisi G, Indolfi C, Umano GR, Klain A, Marchese G, Ghiglioni DG, Zicari AM, Marseglia GL, Miraglia Del Giudice M. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children (Basel). 2021 Aug 31;8(9). doi: 10.3390/children8090769. PMID: 34572201; PMCID: PMC8467017.
Copy Download .nbib Format: NLM
Type 2 diabetes in pediatrics.

Minerva pediatrics

Fornari E, Barbetti F, Iafusco D, Lombardo F, Miraglia Del Giudice E, Rabbone I, Mozzillo E.
PMID: 34286947
Minerva Pediatr (Torino). 2021 Jul 21; doi: 10.23736/S2724-5276.21.06530-7. Epub 2021 Jul 21.

Type 2 diabetes (T2D) in adolescents has become an increasing health concern throughout the world and its prevention and screening should be implemented in pediatric care. As clinical features at presentation, in some cases can be similar to type...

Cite
Fornari E, Barbetti F, Iafusco D, et al. Type 2 diabetes in pediatrics. Minerva Pediatr (Torino). 2021;doi: 10.23736/S2724-5276.21.06530-7.
Fornari, E., Barbetti, F., Iafusco, D., Lombardo, F., Miraglia Del Giudice, E., Rabbone, I., & Mozzillo, E. (2021). Type 2 diabetes in pediatrics. Minerva pediatrics, . https://doi.org/10.23736/S2724-5276.21.06530-7
Fornari, Elena, et al. "Type 2 diabetes in pediatrics." Minerva pediatrics vol. (2021). doi: https://doi.org/10.23736/S2724-5276.21.06530-7
Fornari E, Barbetti F, Iafusco D, Lombardo F, Miraglia Del Giudice E, Rabbone I, Mozzillo E. Type 2 diabetes in pediatrics. Minerva Pediatr (Torino). 2021 Jul 21; doi: 10.23736/S2724-5276.21.06530-7. Epub 2021 Jul 21. PMID: 34286947.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 65 entries